Rysomep-D

Description

Rysomep-D is an ANVIS tablet product combining esomeprazole and domperidone. The original carton states two strips of fifteen tablets each. This 30-tablet presentation is distinct from similarly named capsules, so the full product name and dosage form matter.

Rysomep-D product specification

• Labelled ingredients: Esomeprazole and domperidone
• Strength information: Confirm both ingredient amounts and tablet formulation on the complete supplied label
• Dosage form: Tablets
• Pack presentation: 2 × 15 tablets; 30 tablets in total
• Brand: ANVIS

Ingredient background

Esomeprazole reduces stomach acid and is used for conditions such as acid reflux. Domperidone is an anti-sickness medicine. However, a clinician must assess the need for this fixed combination. First, confirm both strengths on the full label rather than transferring directions from a single-ingredient medicine.

Important precautions

Tell the clinician about heart rhythm problems, liver or kidney disease and previous bleeding from the stomach or gut. Also disclose all other medicines because domperidone has important interactions and cardiac precautions. Do not keep treating persistent digestive symptoms without review. In addition, seek urgent advice for vomiting blood or black stools.

Identifying the original presentation

Before use, match the full name on the outer carton and inner packaging. Also compare the quantitative composition with the prescription or professional recommendation. Similar names and pack colours do not establish that two products have the same formula. Ask a pharmacist to explain any difference before making a substitution.

Inspect the seals, batch details and expiry date of the actual supplied pack. Keep the original packaging and leaflet available for reference. In addition, follow its storage instructions and keep the product out of children’s reach. The pack size describes the contents; it does not define a daily regimen or treatment duration.

Documentation and enquiries

Also review the NHS domperidone precautions. For acid-reducing ingredient background, read the NHS esomeprazole information. However, this reference does not establish the complete specification or approval of this ANVIS product. For further documentation or availability, contact ANVIS with the exact name and presentation. Alternatively, browse the ANVIS product catalogue to compare other products.